• 1
    Pflanz S, Timans JC, Cheung J et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 2002; 16:77990.
  • 2
    Lucas S, Ghilardi N, Li J, Sauvage FJ. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc Natl Acad Sci USA 2003; 100:1504752.
  • 3
    Morishima N, Owaki T, Asakawa M, Kamiya S, Mizuguchi J, Yoshimoto T. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27. J Immunol 2005; 175:168693.
  • 4
    Matsui M, Moriya O, Belladonna M, Kamiya S, Lemonnier F, Yoshimoto T, Akatsuka T. Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. J Virol 2004; 78:9093104.
  • 5
    Yoshimoto T, Okada K, Morishima N et al. Induction of IgG2a class switching in B cells by IL-27. J Immunol 2004; 173:247985.
  • 6
    Pflanz S, Hibbert L, Mattson J et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 2004; 172:222531.
  • 7
    Chen Q, Ghilardi N, Wang H, Baker T, Xie MH, Gurney A, Grewal IS, Sauvage FJ. Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 2000; 407:91620.
  • 8
    Kamiya S, Owaki T, Morishima N, Fukai F, Mizuguchi J, Yoshimoto T. An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells. J Immunol 2004; 173:38717.
  • 9
    Hibbert L, Pflanz S, Malefyt RW, Kastelein R. IL-27 and IFN-alpha signal via Stat1 and Stat3 and induce T-Bet and IL-12Rbeta2 in naive T cells. J Interferon Cytokine Res 2003; 23:51322.
  • 10
    Zahn S, Wirtz S, Birkenbach M, Blumberg R, Neurath M, Stebut E. Impaired Th1 responses in mice deficient in Epstein–Barr virus-induced gene 3 and challenged with physiological doses of Leishmania major. Eur J Immunol 2005; 35:110612.
  • 11
    Yoshida H, Hamano S, Senaldi G et al. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 2001; 15:56978.
  • 12
    Villarino A, Hibbert L, Lieberman L et al. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 2003; 19:64555.
  • 13
    Villarino A, Huang E, Hunter C. Understanding the pro- and anti-inflammatory properties of IL-27. J Immunol 2004; 173:71520.
  • 14
    Ling P, Gately MK, Gubler U et al. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J Immunol 1995; 154:11627.
  • 15
    Oppmann B, Lesley R, Blorn B et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities as well as distinct from IL-12. Immunity 2000; 13:71525.
  • 16
    Gillessen S, Carvajal D, Ling P et al. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol 1995; 25:2006.
  • 17
    Kato K, Shimozato O, Hoshi K, Wakimoto H, Hamada H, Yagita H, Okumura K. Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection. Proc Natl Acad Sci USA 1996; 93:90859.
  • 18
    Shimozato O, Ugai S, Chiyo M et al. The secreted form of p40 subunit of interleukin (IL) -12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects. Immunology 2006; 117:228.
  • 19
    Chiyo M, Shimozato O, Yu L, Kawamura K, Iizasa T, Fujisawa T, Tagawa M. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Int J Cancer 2005; 115:43742.
  • 20
    Oda Y, Funasaka K, Kitano M, Nakano A, Yoshikura T. Use of a high-throughput umu-microplate test system for rapid detection of genotoxicity produced by mutagenic carcinogens and airborne particle matter. Environ Mol Mutagen 2004; 43:109.
  • 21
    Chiyo M, Shimozato O, Iizasa T, Fujisawa T, Tagawa M. Antitumor effects produced by transduction of dendritic cells-derived heterodimeric cytokine genes in murine colon carcinoma cells. Anticancer Res 2004; 24:37637.
  • 22
    Hisada M, Kamiya S, Fujita K, Belladonna M, Aoki T, Koyanagi Y, Mizuguchi J, Yoshimoto T. Potent antitumor activity of interleukin-27. Cancer Res 2004; 64:11526.
  • 23
    Salcedo R, Stauffer J, Lincoln E et al. IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells. J Immunol 2004; 173:717082.
  • 24
    Deverge O, Hummel M, Koeppen H, Le Beau MM, Nathanson EC, Kieff E, Birkenbach M. A novel interleukin-12 p40-related protein induced by latent Epstein–Barr virus infection in B lymphocytes. J Virol 1996; 70:114353.
  • 25
    Stumhofer JS, Laurence A, Wilson EH et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 2006; 7:93745.
  • 26
    Shimizu M, Shimamura M, Owaki T et al. Antiangiogenic and antitumor activities of IL-27. J Immunol 2006; 176:731724.
  • 27
    Segal BM. Experimental autoimmune encephalomyelitis: cytokines, effector T cells, and antigen-presenting cells in a prototypical Th1-mediated autoimmune disease. Curr Allergy Asthma Rep 2003; 3:8693.
  • 28
    Li J, Gran B, Zhang G, Rostami A, Kamoun M. IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis. J Neurol Sci 2005; 232:39.
  • 29
    Wirtz S, Becker C, Fantini M et al. EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-κB activation. J Immunol 2005; 174:281424.
  • 30
    Sonobe Y, Yawata I, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A. Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Res 2005; 1040:2027.
  • 31
    Larousserie F, Pflanz S, Coulomb-L’Hermine A, Brousse N, Kastelein R, Devergne O. Expression of IL-27 in human Th1-associated granulomatous diseases. J Pathol 2004; 202:16471.
  • 32
    Schmidt C, Giese T, Ludwig B, Mueller-Molaian I, Marth T, Zeuzem S, Meuer S, Stallmach A. Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn’s disease but not in ulcerative colitis. Inflamm Bowel Dis 2004; 11:1623.
  • 33
    Aggarwal SA, Ghilardi N, Xie MH, Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003; 278:19104.
  • 34
    Goldberg R, Zohar Y, Wildbaum G, Geron Y, Maor G, Karin N. Suppression of ongoing experimental autoimmune encephalomyelitis by neutralizing the function of the p28 subunit of IL-27. J Immunol 2004; 173:646571.
  • 35
    Goldberg R, Wildbaum G, Zohar Y, Maor G, Karin N. Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28 subunit of IL-27. J Immunol 2004; 173:11718.
  • 36
    Nakajima A, Seroogy CM, Sandora MR et al. Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J Clin Invest 2001; 107:1293301.
  • 37
    Costa GL, Sandora MR, Nakajima A et al. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J Immunol 2001; 167:237987.
  • 38
    Brombacher F, Kastelein RA, Alber G. Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol 2003; 24:20712.